Xi Han

Title: Innovations by Inventor Xi Han

Introduction

Xi Han is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of various cancers. With a total of 2 patents, his work focuses on developing innovative compounds that can aid in cancer treatment.

Latest Patents

Among his latest patents, Xi Han has developed a quinoline derivative for the treatment of nasopharyngeal carcinoma. This invention provides a novel approach to preparing a pharmaceutical composition aimed at tumor treatment. Additionally, he has created another quinoline derivative specifically for treating gastric cancer. This compound, 1-[[[4-(4-fluoro-2-methyl-1H-indol-5-yl)oxy-6-methoxyquinolin-7-yl]oxy]methyl]cyclopropylamine, or its pharmaceutically acceptable salt, hydrate, or prodrug, has shown effectiveness in stabilizing or relieving the condition of gastric cancer patients.

Career Highlights

Throughout his career, Xi Han has worked with various organizations, including Chia Tai Tianqing Pharmaceutical Group Co., Ltd. His expertise in pharmaceutical innovation has positioned him as a key figure in the development of cancer treatments.

Collaborations

Xi Han has collaborated with notable colleagues, including Xunqiang Wang and Jie Chen, who have contributed to his research and development efforts.

Conclusion

Xi Han's innovative work in developing quinoline derivatives for cancer treatment highlights his commitment to advancing medical science. His contributions are paving the way for new therapeutic options in oncology.